ALSV

ATP Life Science Ventures Portfolio holdings

AUM $898M
This Quarter Return
+7.52%
1 Year Return
+84.86%
3 Year Return
5 Year Return
10 Year Return
AUM
$527M
AUM Growth
+$527M
Cap. Flow
+$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
2
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
STOK icon
1
Stoke Therapeutics
STOK
$1.08B
$392M 74.38% 16,786,713
AKRO icon
2
Akero Therapeutics
AKRO
$3.74B
$135M 25.62% 5,415,203